Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiPo Trial: SZC and High Potassium Diet in CKD
NCT04727840Phase 1Unknown
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2021
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by Brigham and Women's Hospital. Primary endpoint: Normalization of Serum Potassium level at 2 days. Status: unknown.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT04727840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04727840.